Picture of Freeline Therapeutics Holdings logo

FRLN — Freeline Therapeutics Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Freeline Reports First Quarter 2022 Results And Business Highlights

May 10 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
BUSINESS HIGHLIGHTS
    * QTRLY LOSS PER SHARE $0.63
    * Q1 EARNINGS PER SHARE VIEW $-0.61 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX10NsH1 
Further company coverage:  FRLN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Freeline Therapeutics Holdings

See all news